TKNO Insider Trading

Insider Ownership Percentage: 15.20%
Insider Buying (Last 12 Months): $15,149,997.60
Insider Selling (Last 12 Months): $0.00

Alpha Teknova Insider Trading History Chart

This chart shows the insider buying and selling history at Alpha Teknova by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10M$0$10MTotal Insider BuyingTotal Insider Selling

Alpha Teknova Share Price & Price History

Current Price: $4.68
Price Change: Price Decrease of -0.19 (-3.90%)
As of 04/4/2025 05:00 PM ET

This chart shows the closing price history over time for TKNO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$4.68Closing price on 04/05/25:

SEC Filings (Institutional Ownership Changes) for Alpha Teknova (NASDAQ:TKNO)

13.81% of Alpha Teknova stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TKNO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$9.01Mbought$2.01MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal InflowsTotal Outflows
Alpha Teknova logo
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Read More on Alpha Teknova

Today's Range

Now: $4.68
Low: $4.48
High: $4.80

50 Day Range

MA: $6.95
Low: $4.68
High: $9.76

52 Week Range

Now: $4.68
Low: $1.16
High: $10.37

Volume

387,393 shs

Average Volume

331,668 shs

Market Capitalization

$250.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.54

Who are the company insiders with the largest holdings of Alpha Teknova?

Alpha Teknova's top insider investors include:
  1. Telegraph Hill Partners Iv, L (Major Shareholder)
  2. Ted Davis (Director)
  3. J Matthew Mackowski (Director)
  4. Stephen Gunstream (CEO)
  5. Matthew Lowell (CFO)
  6. Lisa Hood (Insider)
  7. Damon Terrill (General Counsel)
  8. Ken Gelhaus (Insider)
Learn More about top insider investors at Alpha Teknova.